CONNECTING Healthcare EXPERTISE

THE CLINICIAN EXCHANGE is a virtual exchange designed to pair specific clinical skillsets with specific industry initiatives.

EXCHANGE YOUR EXPERTISE

Learn how you can unlock the power of your expertise and experience to impact the healthcare industry in ways never before imagined

REGISTER NOWLEARN MORE

EXTEND, EXCEL…EXPLORE THE EXCHANGE

Learn how you can cost-effectively multiply your sales, education and R&D resources in an instant

REGISTER NOWLEARN MORE

COMMUNITY PORTAL

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

Reducing Unplanned Acute Care for Patients With Cancer

Published: Mon, 18 Jun 2018 12:00:00 EDT
Early use of palliative care and identification of patients at risk are strategies that may reduce acute care in patients with cancer.
Journal of Oncology Practice

Patient Violence: It's Not All in a Day's Work

Published: Mon, 18 Jun 2018 12:00:00 EDT
What strategies may help nurses manage violent behaviors in patients and minimize the risk of being victimized?
American Nurse Today

Intralesional Laser Therapy for Dermal Filler Complications

Published: Mon, 18 Jun 2018 12:00:00 EDT
Is intralesional laser treatment a safe and effective treatment option for complications caused by dermal filler treatments?
Plastic and Reconstructive Surgery
Displaying results 7-9 (of 20)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

HEALTHCARE SUPPLIER NEWS

Argenx boosts pipeline with new version of lead drug

Published: Thu, 14 Jun 2018 13:56:19 +0000
Argenx has the first data on a new subcutaneous formulation of its rare autoimmune disease drug efgartigimod that could make it a much more patient-friendly prospect.

Harnessing ‘rogue’ stem cells to grow healthy fat could help treat metabolic disorders

Published: Thu, 14 Jun 2018 13:30:49 +0000
Scientists at American University have discovered a potential method for treating obesity by controlling the process by which stem cells differentiate into fat cells. It revolves around dormant cells that have the potential to turn into several tissue types, including healthy fat.

Calliditas files for $75M IPO to fund kidney disease phase 3

Published: Thu, 14 Jun 2018 13:10:32 +0000
Calliditas has filed to raise SEK 650 million ($75 million) through an IPO in Sweden. The financing will set Calliditas up to start enrolling autoimmune kidney disease patients in a pivotal trial later this year.
Displaying results 7-9 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 

HAVE A QUESTION?

 Security code
1-800-4-the-clinx

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top